Skip to content
Biodatica
Start free

British Columbia Cancer Agency

Prince George, British Columbia

OncologyPhase III
Compare Sign in to watch

What changed

Study registered, no phase assigned: Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

3w agoTrial registeredJun 23, 2026Source filing (opens the source filing in a new tab)

Momentum

91no change

Momentum 91 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

258 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Jun 8, 2026

    Breast Cancer Early Stage Breast Cancer (Stage 1-3) · RECRUITING · sponsor: British Columbia Cancer Agency · Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

    ClinicalTrials.gov · NCT06885671 (opens the source filing in a new tab)

  2. Trial

    PHASE3 registered

    Feb 23, 2020

    Head and Neck Cancer, Oropharynx Cancer, Human Papilloma Virus · RECRUITING · sponsor: Centre hospitalier de l'Université de Montréal (CHUM) · Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

    ClinicalTrials.gov · NCT04178174 (opens the source filing in a new tab)

  3. Trial

    NA registered

    Dec 2, 2019

    Neoplasm Metastasis, Neoplastic Processes, Neoplasms, Pathologic Processes · TERMINATED · sponsor: British Columbia Cancer Agency · SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

    ClinicalTrials.gov · NCT03694015 (opens the source filing in a new tab)

  4. Trial

    PHASE3 registered

    Feb 22, 2019

    Metastatic Tumors · ACTIVE_NOT_RECRUITING · sponsor: David Palma · Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

    ClinicalTrials.gov · NCT03721341 (opens the source filing in a new tab)

  5. Trial

    PHASE1 registered

    Aug 9, 2017

    Malignant Neoplasms of Respiratory and Intrathoracic Organs, Squamous Cell Carcinoma of the Larynx · RECRUITING · sponsor: M.D. Anderson Cancer Center · Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

    ClinicalTrials.gov · NCT03114462 (opens the source filing in a new tab)

  6. Trial

    NA registered

    Nov 1, 2016

    Metastatic Tumors · ACTIVE_NOT_RECRUITING · sponsor: British Columbia Cancer Agency · Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

    ClinicalTrials.gov · NCT02933242 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources